Cancer Treatment Denied in Maryland: Guide
Insurance denied cancer treatment in Maryland? Learn MD's clinical trial law, external review rights, Medicaid rules, and how to appeal your insurer's denial.
Maryland is home to the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center — two NCI-designated cancer centers where some of the world's most advanced oncology treatments are offered. Yet Maryland cancer patients regularly face insurance denials for those very treatments. If your insurer has refused to cover chemotherapy, immunotherapy, genetic testing, or clinical trial participation, Maryland law gives you strong rights to appeal.
Maryland's Insurance Landscape
Major health insurers in Maryland include CareFirst BlueCross BlueShield (the state's largest), UnitedHealthcare, Aetna, Kaiser Permanente Mid-Atlantic, and Cigna. Maryland Medicaid — HealthChoice — expanded under the ACA and is administered through managed care organizations including Priority Partners, Amerigroup Maryland, Molina Healthcare, and UnitedHealthcare Community Plan.
The Maryland Insurance Administration (MIA) regulates fully insured commercial health plans. Maryland operates its own ACA exchange (Maryland Health Connection), and the state has taken a proactive approach to insurance regulation. Self-funded ERISA employer plans fall under federal oversight.
State Protections for Cancer Patients
Clinical Trial Mandate: Maryland Insurance Code Section 15-829 requires health insurers to cover routine patient care costs for enrollees participating in qualifying cancer clinical trials. This includes standard physician visits, laboratory tests, imaging, and supportive care. Patients enrolled in trials at Johns Hopkins or University of Maryland should cite this statute when routine care costs are denied.
External Independent Review: Complete Guide" class="auto-link">External Review Rights: Maryland law provides for external review by an IRO after internal appeals are exhausted. For urgent cancer cases, Maryland's expedited external review process must produce a decision within 72 hours. The MIA administers the external review program, and IRO decisions are binding on the insurer.
Oral Chemotherapy Parity: Maryland Insurance Code Section 15-822 requires that oral anticancer drugs be covered at the same cost-sharing level as IV chemotherapy drugs. This has been in place for many years and is actively enforced by the MIA.
Step Therapy Protections: Maryland requires health insurers to provide step therapy exception processes for oncology medications. Oncologists can request exceptions when the required drug is contraindicated or clinically inappropriate.
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →
Maryland Health Care Commission Oversight: Maryland's unique all-payer rate-setting system (hospital rate regulation) adds another layer of transparency to cancer care costs, giving patients data to support appeals.
Common Denial Reasons in Maryland
- Immunotherapy: Checkpoint inhibitors are denied for off-label cancer indications even when Johns Hopkins oncologists document strong supporting evidence.
- Proton therapy: Denied as "not medically necessary" for prostate cancer, pediatric tumors, and head and neck cancers despite institutional expertise.
- Genetic testing: Hereditary cancer panels and tumor genomic profiling are denied despite NCCN guidelines supporting their use in treatment planning.
- Targeted therapy: Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization processes create weeks-long delays for precision oncology drugs.
- HealthChoice denials: Maryland Medicaid enrollees face additional scrutiny from managed care organizations applying restrictive prior authorization to newer cancer treatments.
How to Appeal a Cancer Denial in Maryland
Step 1 — Internal Appeal: File a written appeal within your plan's deadline, typically 180 days from the denial. Include your oncologist's letter of medical necessity, NCCN guidelines, peer-reviewed evidence, and Maryland Insurance Code Section 15-829 where applicable.
Step 2 — Expedited Internal Review: Request expedited processing when your oncologist certifies that delay would harm your health. Insurers must respond within 72 hours.
Step 3 — External Review via MIA: After exhausting internal appeals, file for external review through the Maryland Insurance Administration. Call 1-800-492-6116 or visit insurance.maryland.gov. IRO decisions are binding on the insurer.
Step 4 — MIA Complaint: File a formal complaint with the Maryland Insurance Administration if your insurer violates state law. MIA has strong enforcement authority and investigates insurer conduct.
State and Community Resources
- Johns Hopkins Sidney Kimmel Cancer Center Patient Support: Social workers and financial counselors at Johns Hopkins assist with insurance denials and benefit navigation.
- University of Maryland Greenebaum Cancer Center Navigation: Insurance navigators help patients challenge coverage denials.
- Maryland Cancer Fund: Provides supplemental financial assistance for cancer treatment for qualifying Maryland residents.
- American Cancer Society (ACS) Helpline: 1-800-227-2345, available 24/7 for Maryland cancer patients needing insurance guidance, transportation support, and local connections.
Key Laws to Cite in Your Appeal
- Maryland Insurance Code § 15-829 (clinical trial routine cost coverage)
- Maryland Insurance Code § 15-822 (oral chemotherapy parity)
- Maryland Insurance Code § 15-10A-01 et seq. (external review rights)
- Women's Health and Cancer Rights Act (federal)
- ACA Section 2719 (internal and external appeals)
Fight Back With ClaimBack
ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.
Fight your denial at ClaimBack →
Related Reading:
How much did your insurer deny?
Enter your denied claim amount to see what you could recover.
Your insurer is counting on you giving up.
Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.
We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.
Free analysis · No credit card · Takes 3 minutes
Related ClaimBack Guides